CPXCR1 antibody (AA 151-250) (Cy7)
Quick Overview for CPXCR1 antibody (AA 151-250) (Cy7) (ABIN1416332)
Target
See all CPXCR1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 151-250
-
Predicted Reactivity
- Human,Horse
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human CPXCR1
-
Isotype
- IgG
-
-
-
-
Application Notes
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Expiry Date
- 12 months
-
-
- CPXCR1 (CPX Chromosome Region, Candidate 1 (CPXCR1))
-
Alternative Name
- CPXCR1
-
Background
-
Synonyms: Cancer/testis antigen 77, CPX chromosome region, candidate 1, CPX candidate region 1 protein, CPX chromosomal region candidate gene 1 protein, CPX chromosomal region candidate gene 1 protein homolog, CPX chromosome region, candidate 1, CT77, Gm1143, CPXCR_HUMAN.
Background: CPXCR1 is widely expressed in fetal tissues, including the tongue, mandible and palate with an unknown function. Cleft palate most commonly occurs as a sporadic multifactorial disorder with a clear but difficult to define genetic component. As a semi-dominant disorder, X-linked cleft palate (CPX) provides a useful model to investigate a congenital defect that is little influenced by non-genetic factors.
-
Gene ID
- 53336
Target
-